Upgrade to SI Premium - Free Trial

Oppenheimer Raises Price Target on Medtronic (MDT) to $94 Following EPS Beat

August 26, 2016 9:44 AM
Oppenheimer reiterated an Outperform rating on Medtronic, Inc. (NYSE: MDT), and raised the price target to $94.00 (from $90.00), following ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles